EUVIMEDEUVIMED entdecken
Crossref

Altered Gene Expression of Cytochrome P450 and ABC Transporter in Human Hepatocellular Carcinoma HepG2 Cells Exposed to Bardoxolone Methyl

Katsuhito Nagai, Shuhei Fukuno, Takeshi Miura, Eri Yasuda-Imanishi, Hiroki Konishi

Drug Research · 01.10.2023 · 73 (08) · 473-475

DOI: 10.1055/a-2111-6649 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Research, erschienen am 01.10.2023. Verfasst von Katsuhito Nagai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Osaka Ohtani University, Nishikiori-kita, Tondabayashi, Japan. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bardoxolone methyl (BX) is expected to be an innovate therapeutic agent for chronic kidney disease (CKD). The aim of the present study was to examine whether the expression of subtypes of cytochrome P450 (CYP) and ABC transporters was altered in human hepatocellular carcinoma HepG2 cells by exposure to BX. The expression of mRNAs for CYP1A2, CYP2E1, P-glycoprotein, multidrug resistance-associated protein 1–3, and breast cancer resistance protein was significantly increased by exposure of HepG2 cells to BX, while the expression of CYP3A4 mRNA was significantly decreased under the same conditions. BX had no significant effect on the expression of mRNAs for CYP2C9 and CYP2C19 in HepG2 cells. In conclusion, this study demonstrated that the gene expression of several CYPs and ABC transporters in HepG2 cells was altered when exposed to BX, suggesting the need to pay careful attention to drug-drug interactions in patients receiving BX for CKD treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsRenal Insufficiency, ChronicHumansATP Binding Cassette Transporter, Subfamily G, Member 2ATP-Binding Cassette TransportersHep G2 CellsNeoplasm ProteinsCytochrome P-450 Enzyme SystemCytochrome P-450 CYP3AGene ExpressionOleanolic Acid

Substanzen

ATP Binding Cassette Transporter, Subfamily G, Member 2ATP-Binding Cassette TransportersNeoplasm ProteinsCytochrome P-450 Enzyme SystemCytochrome P-450 CYP3Abardoxolone methylOleanolic Acid

Autor:innen und Institutionen

  • Laboratory of Clinical Pharmacy and Therapeutics, Faculty of Pharmacy, Osaka Ohtani University, Nishikiori-kita, Tondabayashi, Japan.
  • Pharmaceutical Education Support Center, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women's University, Koshien, Bancho, Nishinomiya, Japan.

Zitieren

APA

Nagai, K., Fukuno, S., Miura, T., Yasuda-Imanishi, E., & Konishi, H. (2023). Altered Gene Expression of Cytochrome P450 and ABC Transporter in Human Hepatocellular Carcinoma HepG2 Cells Exposed to Bardoxolone Methyl. Drug Research, 73(08), 473-475. https://doi.org/10.1055/a-2111-6649

Vancouver

Nagai K, Fukuno S, Miura T, Yasuda-Imanishi E, Konishi H. Altered Gene Expression of Cytochrome P450 and ABC Transporter in Human Hepatocellular Carcinoma HepG2 Cells Exposed to Bardoxolone Methyl. Drug Research. 2023;73(08):473-475. doi:10.1055/a-2111-6649

BibTeX
@article{Nagai2023,
  author = {Nagai, Katsuhito and Fukuno, Shuhei and Miura, Takeshi and Yasuda-Imanishi, Eri and Konishi, Hiroki},
  title = {Altered Gene Expression of Cytochrome P450 and ABC Transporter in Human Hepatocellular Carcinoma HepG2 Cells Exposed to Bardoxolone Methyl},
  journal = {Drug Research},
  year = {2023},
  volume = {73},
  number = {08},
  pages = {473--475},
  doi = {10.1055/a-2111-6649}
}
Kostenlos starten →